1. Home
  2. ITRM vs MLSS Comparison

ITRM vs MLSS Comparison

Compare ITRM & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.03

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Logo Milestone Scientific Inc.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.37

Market Cap

22.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRM
MLSS
Founded
2015
1989
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
22.1M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
ITRM
MLSS
Price
$0.03
$0.37
Analyst Decision
Buy
Buy
Analyst Count
2
1
Target Price
$9.00
$1.00
AVG Volume (30 Days)
30.9M
515.3K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
57.43
N/A
EPS
N/A
N/A
Revenue
N/A
$8,973,982.00
Revenue This Year
N/A
$12.64
Revenue Next Year
$947.65
$8.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.99
52 Week Low
$0.03
$0.22
52 Week High
$1.16
$1.01

Technical Indicators

Market Signals
Indicator
ITRM
MLSS
Relative Strength Index (RSI) 26.10 56.21
Support Level N/A $0.25
Resistance Level $0.39 $0.42
Average True Range (ATR) 0.02 0.04
MACD -0.01 -0.00
Stochastic Oscillator 3.34 41.31

Price Performance

Historical Comparison
ITRM
MLSS

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

Share on Social Networks: